Cross Country Healthcare, Inc. (NASDAQ:CCRN) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Monday. The firm presently has a $13.00 price target on the business services provider’s stock. Zacks Investment Research‘s target price points to a potential upside of 5.09% from the company’s current price.

According to Zacks, “Cross Country, Inc. is a provider of healthcare staffing services. They also provide staffing of clinical research professionals and allied healthcare professionals, such as radiology technicians, rehabilitation therapists and respiratory therapists. Their staffing operations are complemented by other human capital management services, including search and recruitment, consulting, education and training and resource management services. “

A number of other research firms have also issued reports on CCRN. Benchmark Co. reduced their target price on shares of Cross Country Healthcare from $19.00 to $18.00 and set a “buy” rating on the stock in a report on Thursday, May 4th. BidaskClub lowered shares of Cross Country Healthcare from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th. UBS AG restated a “buy” rating and issued a $15.00 target price (down from $16.50) on shares of Cross Country Healthcare in a report on Wednesday, June 14th. Finally, BMO Capital Markets reduced their target price on shares of Cross Country Healthcare from $18.00 to $15.00 and set an “outperform” rating on the stock in a report on Friday, May 5th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $15.64.

Shares of Cross Country Healthcare (NASDAQ:CCRN) traded up 3.00% during trading on Monday, reaching $12.37. 255,616 shares of the company’s stock were exchanged. The stock’s market capitalization is $441.00 million. Cross Country Healthcare has a 52 week low of $10.53 and a 52 week high of $16.38. The stock has a 50 day moving average price of $12.47 and a 200-day moving average price of $13.48.

Cross Country Healthcare (NASDAQ:CCRN) last released its earnings results on Wednesday, August 2nd. The business services provider reported $0.16 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.09 by $0.07. The company had revenue of $209.31 million for the quarter, compared to analyst estimates of $209.92 million. Cross Country Healthcare had a net margin of 1.06% and a return on equity of 12.78%. The firm’s quarterly revenue was up 4.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.16 EPS. Analysts predict that Cross Country Healthcare will post $0.61 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Cross Country Healthcare, Inc. (CCRN) Upgraded by Zacks Investment Research to “Buy”” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this report on another website, it was stolen and republished in violation of US and international copyright laws. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/08/07/cross-country-healthcare-inc-ccrn-upgraded-by-zacks-investment-research-to-buy.html.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. State Board of Administration of Florida Retirement System raised its position in shares of Cross Country Healthcare by 10.0% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 26,646 shares of the business services provider’s stock valued at $416,000 after buying an additional 2,420 shares during the last quarter. State Street Corp raised its position in shares of Cross Country Healthcare by 4.5% in the fourth quarter. State Street Corp now owns 725,878 shares of the business services provider’s stock valued at $11,328,000 after buying an additional 30,988 shares during the last quarter. Renaissance Technologies LLC raised its position in shares of Cross Country Healthcare by 244.1% in the fourth quarter. Renaissance Technologies LLC now owns 158,018 shares of the business services provider’s stock valued at $2,467,000 after buying an additional 112,101 shares during the last quarter. Teachers Advisors LLC raised its position in shares of Cross Country Healthcare by 96.3% in the fourth quarter. Teachers Advisors LLC now owns 129,104 shares of the business services provider’s stock valued at $2,015,000 after buying an additional 63,341 shares during the last quarter. Finally, Louisiana State Employees Retirement System raised its position in shares of Cross Country Healthcare by 0.8% in the first quarter. Louisiana State Employees Retirement System now owns 13,400 shares of the business services provider’s stock valued at $192,000 after buying an additional 100 shares during the last quarter. Institutional investors and hedge funds own 90.00% of the company’s stock.

About Cross Country Healthcare

Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.

Get a free copy of the Zacks research report on Cross Country Healthcare (CCRN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.